Amyloidosis

Written by

in

 

Amyloidosis: High-Yield Pathology

Amyloidosis is a complex disease characterized by the extracellular deposition of abnormal, misfolded, insoluble protein fibrils. These fibrils aggregate into a cross-β-pleated sheet conformation, causing pressure atrophy and structural destruction of neighboring parenchymal cells.

1. Staining & Diagnostic Hallmarks

The definitive identification of amyloid rests entirely on specific optical properties rather than gross appearance:

Stain / Technique Pathological Visualization
Light Microscopy Appears as an amorphous, eosinophilic, acellular extracellular matrix under standard Hematoxylin & Eosin (H&E). Can easily be mistaken for hyaline sclerosis.
Congo Red Stain Demonstrates a characteristic pink-to-red color under standard brightfield light microscopy.
Polarized Light When Congo Red-stained tissue is split with polarized filters, it reveals a pathognomonic apple-green birefringence. This optical behavior is caused by the regular physical geometry of the β-pleated sheets.

2. Main Clinical Subtypes

Subtype Precursor Protein Classic Clinical Etiology & Associations
AL
(Primary)		 Amyloid Light Chain
(typically λ light chains)		 Caused by monoclonal plasma cell proliferations. Highly associated with Multiple Myeloma and Waldenström macroglobulinemia.
AA
(Secondary)		 Amyloid Associated
(cleaved from serum amyloid A)		 Driven by long-standing chronic inflammatory conditions. Classically seen in Rheumatoid Arthritis, Inflammatory Bowel Disease, Osteomyelitis, and Familial Mediterranean Fever (FMF).
ATTR Transthyretin
(Mutated or Wild-Type)		 • Mutated ATTR: Hereditary systemic amyloidosis causing restrictive cardiomyopathy and neuropathy.
• Wild-Type ATTR: Senile Systemic Amyloidosis, predominantly accumulating in the hearts of elderly males.
Aβ Amyloid β protein Derived from the amyloid precursor protein (APP) on Chromosome 21. Forms the core of cerebral plaques in Alzheimer’s Disease and Down Syndrome.
Isolated Organ Calcitonin / Amylin • **Medullary Thyroid Carcinoma:** Tumor stroma shows amyloid from procalcitonin.
• **Type 2 Diabetes Mellitus:** **Amylin (IAPP)** deposits damage pancreatic islet cells.

3. Organ Manifestations & Morphology

  • Kidneys: The most common and serious site of systemic involvement. Deposits settle initially within the glomeruli (mesangium and basement membranes), causing massive capillary permeability shifts. Clinically manifests as severe **Nephrotic Syndrome** progressing to chronic renal failure.
  • Spleen: Produces two unique gross architectural patterns:
    • Sago Spleen: Deposits are strictly confined to the splenic follicles, appearing as pale, translucent granules mimicking sago grains.
    • Lardaceous Spleen: Deposits target the red pulp sinusoids, preserving the follicles but mapping into broad, map-like waxy zones.
  • Heart: Classically causes a rigid, non-compliant ventricular wall leading to **Restrictive Cardiomyopathy** and conduction system arrhythmias. On echocardiography, it displays a characteristic “speckled” or “granular” myocardial pattern.
  • Gastrointestinal: Macroglossia (massive enlargement of the tongue) is a highly specific physical sign pointing toward AL amyloidosis. Malabsorption can occur if fibrils infiltrate the small intestinal villi.

4. High-Yield Exam Pearls

  • Screening Site: The preferred, least invasive clinical site for screening systemic amyloidosis is an **Abdominal Fat Pad Aspirate/Biopsy** or a rectal biopsy, both showing high diagnostic sensitivity when stained with Congo Red.
  • $\beta_2$-Microglobulin Amyloidosis: Occurs in patients on long-term **hemodialysis**. The protein cannot pass through standard dialysis membranes, leading to systemic accumulation with a unique tropism for joints, presenting as **Carpal Tunnel Syndrome**.